Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEFLUNOMIDE vs LENIOLISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEFLUNOMIDE vs LENIOLISIB: Safety Overview

Metric LEFLUNOMIDE LENIOLISIB
Total FAERS Reports 56,539 570
Deaths Reported 5,283 6
Death Rate 9.3% 1.1%
Hospitalizations 13,923 54
Average Patient Age 51.3 yrs 19.4 yrs
% Female Patients 87.3% 27.3%
FDA Approval Date Apr 24, 2019 Mar 24, 2023
Manufacturer Alembic Pharmaceuticals Inc. Pharming Healthcare Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription